Circular RNA circREPS2 Acts as a Sponge of miR-558 to Suppress Gastric Cancer Progression by Regulating RUNX3/β-catenin Signaling.
EMT
RUNX3
circREPS2
gastric cancer
miR-558
Journal
Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621
Informations de publication
Date de publication:
04 Sep 2020
04 Sep 2020
Historique:
received:
19
01
2020
revised:
17
03
2020
accepted:
24
06
2020
pubmed:
30
7
2020
medline:
30
7
2020
entrez:
30
7
2020
Statut:
ppublish
Résumé
Circular RNAs (circRNAs) play an essential regulatory role in multiple cancers. However, the role of a large number of circRNAs in gastric cancer (GC) is still unknown. Here, hsa_circ_0139996 (circREPS2), a novel circRNA that was significantly downregulated in GC, was selected for further investigation. circREPS2 was validated and analyzed by DNA sequencing and quantitative real-time PCR. The roles of circREPS2 in GC cells were verified by gain- and loss-of-function experiments. Bioinformatics analysis, luciferase reporter, RNA pull-down, and RNA immunoprecipitation assays were performed to evaluate the functional mechanism of circREPS2 on microRNA-558 (miR-558)/RUNX3/β-catenin axis in GC cells. In the present study, we found that circREPS2 was downregulated in GC tissues and cell lines. Low expression of circREPS2 was associated with a higher tumor-node-metastasis (TNM) stage, poor tumor differentiation, and larger tumor size in GC patients. Functionally, circREPS2 significantly inhibited GC cell proliferation, migration, invasion, and epithelial-mesenchymal transformation (EMT) in vitro and tumorigenesis in vivo. Furthermore, our data demonstrated that circREPS2 acted as a miR-558 sponge and upregulated RUNX3 expression to inactivate β-catenin signaling in GC cells. In conclusion, circREPS2 suppresses the progression of GC via miR-558/RUNX3/β-catenin signaling and is a novel promising biomarker and target for GC treatment.
Identifiants
pubmed: 32721878
pii: S2162-2531(20)30187-6
doi: 10.1016/j.omtn.2020.06.026
pmc: PMC7390859
pii:
doi:
Types de publication
Journal Article
Langues
eng
Pagination
577-591Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Références
RNA Biol. 2016;13(1):34-42
pubmed: 26669964
J Gastrointest Surg. 2016 Oct;20(10):1692-8
pubmed: 27412320
Mol Cancer. 2019 Oct 29;18(1):149
pubmed: 31660951
Nucleic Acids Res. 2015 Jan;43(Database issue):D146-52
pubmed: 25378301
Oncogene. 2012 Sep 27;31(39):4302-16
pubmed: 22231444
J Exp Clin Cancer Res. 2018 Dec 27;37(1):325
pubmed: 30591054
Genome Med. 2019 Mar 20;11(1):15
pubmed: 30894216
Genome Biol. 2019 Sep 2;20(1):185
pubmed: 31477170
Lancet. 2015 Mar 14;385(9972):977-1010
pubmed: 25467588
Cell. 2016 Jun 30;166(1):21-45
pubmed: 27368099
Lancet. 2016 Nov 26;388(10060):2654-2664
pubmed: 27156933
Elife. 2015 Aug 12;4:
pubmed: 26267216
Nat Rev Mol Cell Biol. 2016 Apr;17(4):205-11
pubmed: 26908011
RNA. 2014 Nov;20(11):1666-70
pubmed: 25234927
Biochim Biophys Acta. 2009 Dec;1796(2):315-31
pubmed: 19682550
PLoS One. 2018 Oct 18;13(10):e0206239
pubmed: 30335862
Cold Spring Harb Perspect Biol. 2010 Feb;2(2):a002915
pubmed: 20182623
Nucleic Acids Res. 2017 Jan 4;45(D1):D90-D96
pubmed: 27742822
Nat Commun. 2019 Sep 20;10(1):4317
pubmed: 31541092
Nat Rev Cancer. 2013 Feb;13(2):97-110
pubmed: 23344542
EBioMedicine. 2019 Oct;48:316-331
pubmed: 31648990
Cell Prolif. 2019 Mar;52(2):e12548
pubmed: 30507050
Cancer Lett. 2015 Sep 1;365(2):141-8
pubmed: 26052092
RNA Biol. 2017 May 4;14(5):514-521
pubmed: 26649774
Nucleic Acids Res. 2018 Jan 4;46(D1):D360-D370
pubmed: 29194489
BMC Bioinformatics. 2013;14 Suppl 2:S4
pubmed: 23369107
Stem Cells. 2012 Oct;30(10):2088-99
pubmed: 22899304
Cell Res. 2012 Jan;22(1):237-47
pubmed: 21826110
Gastroenterology. 2018 Sep;155(3):799-814.e13
pubmed: 29775598
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Cancer Cell. 2008 Sep 9;14(3):226-37
pubmed: 18772112
Nat Rev Genet. 2019 Nov;20(11):675-691
pubmed: 31395983
Aging (Albany NY). 2019 Nov 13;11(21):9689-9708
pubmed: 31719211
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Mol Ther Nucleic Acids. 2020 Jun 5;20:308-322
pubmed: 32193155